- Erythromycin B
-
-
2025-12-16
- CAS:527-75-3
- Min. Order: 10mg
- Purity: 98
- Supply Ability: 100000
|
| | ERYTHROMYCIN B Basic information |
| Product Name: | ERYTHROMYCIN B | | Synonyms: | ERYTHROMYCIN B (150 MG);12-deoxy-erythromyci;12-deoxyerythromycin;abbot24091;Erythromycin B (100 mg);12-DeoxyerythroMycin, BerythroMycin;Erythromycin B/3R,4S,5S,6R,7R,9R,11R,12S,13R,14R)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12-dihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-3,5,7,9,11,13-hex;Erythromycin Impurity 2 | | CAS: | 527-75-3 | | MF: | C37H67NO12 | | MW: | 717.93 | | EINECS: | | | Product Categories: | | | Mol File: | 527-75-3.mol |  |
| | ERYTHROMYCIN B Chemical Properties |
| Melting point | 191-195 °C | | Boiling point | 807.6±65.0 °C(Predicted) | | density | 1.17±0.1 g/cm3(Predicted) | | solubility | Chloroform (Slightly), Ethanol (Slightly), Ethyl Acetate (Slightly, Heated) | | pka | 13.49±0.70(Predicted) |
| Hazard Codes | Xi | | Risk Statements | 36 | | Safety Statements | 26 | | HS Code | 2941500000 |
| | ERYTHROMYCIN B Usage And Synthesis |
| Uses | Erythromycin B is a co-metabolite of Erythromycin A (E649950), an antibacterial agent. | | Uses | Erythromycin B (12-deoxyerythromycin A) is a minor co-metabolite of erythromycin produced Saccharopolyspora erythreae. Erythromycin B exhibits broad spectrum antibiotic activity, albeit less potent than erythromycin A. Erythromycin B played an integral part of the SAR studies of semi-synthetic erythromycins, however none reached clinical development. | | Definition | ChEBI: Erythromycin B is an erythromycin that consists of erythronolide B having 2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl and 3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl residues attahced at positions 4 and 6 respectively. It is functionally related to an erythronolide B. |
| | ERYTHROMYCIN B Preparation Products And Raw materials |
|